Exponent price target raised to $85 from $81 at UBS

UBS analyst Joshua Chan raised the firm’s price target on Exponent (EXPO) to $85 from $81 and keeps a Neutral rating on the shares. The Q4 results and 2026 guidance were largely consistent with consensus, but given that guidance typically leans conservative, there could be perceived upside potential through the year against a stock that has de-rated over much of the past year, the analyst tells investors in a research note.